ArticleBMC gastroenterology2025

Efficacy and safety of programmed death-1 inhibitors combined with chemotherapy in patients with advanced gastric cancer.

Xiaofei Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.